Sebastian Wanless
Corporate Officer/Principal presso TCB Newco Ltd.
Profilo
Sebastian Wanless is currently working as a Senior Clinical Director at TCB Newco Ltd.
He previously worked as a Senior Medical Director at Bristol-Myers Squibb Foundation from 2003 to 2007.
Additionally, he worked as a Director-Clinical Operations at TC Biopharm (Holdings) Plc from 2020 to 2022.
Posizioni attive di Sebastian Wanless
Società | Posizione | Inizio |
---|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
Precedenti posizioni note di Sebastian Wanless
Società | Posizione | Fine |
---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 01/09/2022 |
Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 01/01/2007 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Aziende private | 2 |
---|---|
Bristol-Myers Squibb Foundation | |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Borsa valori
- Insiders
- Sebastian Wanless